Home › Funds › JTC Employer Solutions Trustee Ltd › GSK
JTC Employer Solutions Trustee Ltd position in GSK
GSK PLC · Health Care
JTC Employer Solutions Trustee Ltd reported holding 8,077,477 shares of GSK (GSK PLC) in its Q3 2026 13F filing — a position valued at US$389.2M, representing 33.51% of its reported portfolio and ranking #1 among its reported holdings. JTC Employer Solutions Trustee Ltd has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How JTC Employer Solutions Trustee Ltd's GSK position evolved
JTC Employer Solutions Trustee Ltd first disclosed a stake in GSK in Q3 2023 at 12,444,460 shares (US$451.1M). The position peaked in Q1 2024 at 21,141,012 shares, worth US$909.1M. Across 13 filings, JTC Employer Solutions Trustee Ltd increased the stake 1 time(s), trimmed it 11 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 8,077,477 shares valued at US$389.2M — a reduction of -515,510 shares quarter over quarter.. Notable position changes include a 71% increase in Q1 2024 (shares fell 10% over the following quarter), a 37% trim in Q1 2026 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 12.44M | $451.11M | New |
| Q4 2023 | 12.34M | $457.76M | Reduce |
| Q1 2024 | 21.14M | $909.06M | Add |
| Q2 2024 | 20.88M | $803.79M | Reduce |
| Q3 2024 | 20.48M | $837.36M | Reduce |
| Q4 2024 | 20.28M | $682.27M | Reduce |
| Q1 2025 | 15.26M | $591.57M | Reduce |
| Q2 2025 | 15.00M | $575.67M | Reduce |
| Q3 2025 | 14.60M | $629.94M | Reduce |
| Q4 2025 | 14.43M | $707.69M | Reduce |
| Q1 2026 | 9.04M | $498.91M | Reduce |
| Q2 2026 | 8.59M | $450.31M | Reduce |
| Q3 2026 | 8.08M | $389.17M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GSK and 13F data
GSK (GSK PLC) is a Health Care company. 19 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.21B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GSK
- Dodge & Cox 48.20M sh · $2.53B · Q2 2026
- DODGE & COX 48.20M sh · $2.53B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 25.19M sh · $1.21B · Q3 2026
- Mondrian Investment Partners LTD 4.97M sh · $239.21M · Q3 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 3.92M sh · $188.73M · Q3 2026
- EQUITY INVESTMENT CORP 3.56M sh · $171.52M · Q3 2026
More on JTC Employer Solutions Trustee Ltd
FAQ
How long has JTC Employer Solutions Trustee Ltd held GSK?
JTC Employer Solutions Trustee Ltd has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is JTC Employer Solutions Trustee Ltd's current position in GSK?
As of Q3 2026, JTC Employer Solutions Trustee Ltd holds 8.08M shares of GSK (GSK PLC), valued at $389.17M, representing 33.51% of its reported portfolio and ranking #1.
Has JTC Employer Solutions Trustee Ltd been buying or selling GSK?
In the latest 13F filing (Q3 2026), JTC Employer Solutions Trustee Ltd reduced its position in GSK. The position peaked in Q1 2024 at 21.14M shares.
Which other funds hold GSK?
Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.